These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7418986)

  • 21. Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
    Lee DH; Jang PS; Chung NG; Cho B; Jeong DC; Kim HK
    Exp Hematol; 2013 Jun; 41(6):539-46. PubMed ID: 23415674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of cisplatin antitumour activity by Ethyldeshydroxy-Sparsomycin in L1210 leukemia.
    Hofs HP; Wagener DJ; De Valk-Bakker V; Van Rennes H; Van Zeist AJ; Van Den Broek LA; Ottenheijm HC
    Anticancer Res; 1992; 12(1):167-70. PubMed ID: 1567164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y; Kato T; Ueda R; Ota K
    Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism by tricyclic antidepressants of reserpine-induced hypothermia in mice. Involvement of postsynaptic alpha 2-adrenoceptors.
    Przegaliński E; Siwanowicz J; Baran L; Bigajska K
    Pol J Pharmacol Pharm; 1983; 35(4):309-17. PubMed ID: 6320144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological studies on DL-1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide, a new antitumor agent (author's transl)].
    Yamada K; Koshiura R; Miyamoto K; Sanae F
    Yakugaku Zasshi; 1980 Mar; 100(3):347-54. PubMed ID: 7381688
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect and toxicity of combination treatment including cyclocytidine or cytosine arabinoside in L-1210 and sarcoma-180 systems.
    Hoshi A; Kanzawa F; Iigo M; Kuretani K
    Gan; 1975 Oct; 66(5):539-46. PubMed ID: 1220992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia.
    Zager RF; Frisby SA; Oliverio VT
    Cancer Res; 1973 Jul; 33(7):1670-6. PubMed ID: 4124487
    [No Abstract]   [Full Text] [Related]  

  • 29. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
    Walker EM; Gale GR
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of methyl o-(4-hydroxy-3-methoxycinnamoyl) reserpate (CD-3400) on erection and ejaculation in dogs].
    Yonezawa A; Tadano T; Urano S; Kisara K; Kimura Y
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):239-49. PubMed ID: 6130031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An improved method for analyzing survival data from combination chemotherapy experiments.
    Carter WH; Stablein DM; Wampler GL
    Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].
    Bukhman VM; Lichinitser MR; Svet-Moldavskiĭ GIa; Mkheidze DM
    Biull Eksp Biol Med; 1978 Mar; 85(3):340-3. PubMed ID: 276385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection.
    Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Cros S; Paoletti C
    Cancer Res; 1976 Sep; 36(9 pt.1):3067-76. PubMed ID: 975074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reserpine, rescinnamine, and deserpidine content of Rauwolfia roots.
    BANES D; HOUK AE; WOLFF J
    J Am Pharm Assoc Am Pharm Assoc; 1958 Sep; 47(9):625-7. PubMed ID: 13575224
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of reserpine and syrosingopine upon pentobarbital depression.
    Ponessa JT; De Boer B
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):67-70. PubMed ID: 4382038
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination therapy of mouse leukemia L1210 by 1-beta-D-arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine.
    Cass CE; Muzik H; Paterson AR
    Cancer Res; 1975 May; 35(5):1187-93. PubMed ID: 1120308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microchemical investigation of medicinal plants. VI. Estimation of reserpine and rescinnamine in Rauwolfia.
    McGahren WJ; Chuntragool S; Trunphong P; Ma TS
    Mikrochim Acta; 1969; (5):1100-6. PubMed ID: 4390268
    [No Abstract]   [Full Text] [Related]  

  • 40. The action of compound WA-335 on the central nervous system.
    Maj J; Baran L; Sowińska H; Gancarczyk L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.